The human multidrug resistance-associated protein MRP confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Recent evidence indicates that MRP can also transport glutathione S-conjugates across membranes. To study the transport properties of MRP in intact cells, we have expressed human MRP cDNA in the polarized pig kidney epithelial cell line LLC-PK1. MRP mainly localized to the basolateral plasma membrane of these cells, and not to the apical membrane, as determined by immunocytochemistry using confocal laser scanning and electron microscopy. In accordance with this localization, MRP caused increased transport of the glutathione S -conjugate S -(2, 4-dinitrophenyl)-glutathione and of the anticancer drug daunorubicin to the basal side of the epithelial cell layer. Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport, inhibited this basolateral transport, but not the apical transport of daunorubicin mediated by the apically localized human MDR1 P-glycoprotein in MDR1 -transfected LLC-PK1 cells. Probenecid and sulfinpyrazone may therefore be useful lead compounds for the development of clinical reversal agents specific for MRP-mediated drug resistance. ( J. Clin. Invest. 1996.
Introduction
Upon exposure to a single cytotoxic drug, mammalian tumor cells can develop resistance against a range of drugs with different chemical structures and cellular targets (1). This phenomenon is called multidrug resistance (MDR) 1 . Thus far, two proteins have been identified that can confer MDR: P-glycoprotein (Pgp) , and the multidrug resistance-associated protein (MRP; 2). Both are members of the ATP-binding cassette family of transporter proteins, and both confer resistance by decreasing the intracellular concentration of cytotoxic drugs (1, 3, 4) . Pgp is a 140-170 kD plasma membrane protein that actively extrudes a range of relatively hydrophobic, amphiphilic, drugs from the cell. MRP is a 190-kD membrane protein, which is also mainly present in the plasma membrane of resistant cells (4) (5) (6) .
Recent studies suggest that the exact mechanism by which MRP and Pgp remove drugs from the cell may be fundamentally different. Inside-out plasma membrane vesicles isolated from MRP -overexpressing cells showed an increased ATPdependent glutathione S -conjugate uptake activity (7, 8) . The experiments indicated that MRP is able to transport substrates that are conjugated to glutathione (GSH). Carriers with this property are known as GS-X pumps (9) , multispecific anion transporters (10) , or the leukotriene C 4 transporter (7, 11) , and they have a relatively broad substrate specificity. They can transport substrates containing a hydrophobic and a negatively charged part (9, 10) . In vitro evidence supporting that MRP mediates the transport of GS-X pump substrates was obtained by showing that leukotriene C 4 can be cross-linked to a 190-kD protein that is recognized by an antiserum against MRP (7) . Evidence that the presence of GSH is a prerequisite for MRP-mediated MDR in intact cells was obtained by depleting cells of GSH by treatment with l -buthionine sulfoximine, an inhibitor of GSH synthesis. l -buthionine sulfoximine treatment resulted in the loss of resistance to doxorubicine, daunorubicine, vincristine and VP16 (12) (13) (14) .
MRP expression is found in all major organs analyzed and in all cell types from peripheral blood (15, 16) , but its exact physiological function is not yet known. Pgp is found in the brush border of proximal tubules of the kidney, in the bile canalicular membrane of hepatocytes, in the apical membrane of mucosal cells in the intestine, and in the luminal membrane of endothelial cells at blood-tissue barrier sites (17, 18) . The distribution of Pgp indicates that it can protect the organism against toxic xenobiotic compounds, which was confirmed by disrupting a Pgp gene in mice (19) . For MRP several potential physiological functions can be envisaged, including a role in inflammation due to its capacity to transport leukotriene C 4 (9) , and, in analogy with Pgp, a more general role in detoxification of cells by the export of GSH and other conjugates of potentially noxious compounds.
To study the transport characteristics of MRP in polarized cells, we have transfected MRP cDNA into the epithelial pig kidney cell line LLC-PK1. Transfection of the MDR1 P-glycoprotein cDNA in this type of cells has yielded useful information regarding transport properties of this protein, which is predominantly found in the apical plasma membrane of these cells (20, 21 (4) . The calcium phosphate coprecipitation technique was used (22, 23) . Transfected populations were selected for 2 wk with G418 (800 g/ml), supplemented after 1 wk with 160 nM vincristine. 2 wk after the transfection, selection was reduced to 40 nM vincristine only. LLC-MDR1 (21) was obtained by transfecting LLC-PK1 cells with the expression vector pFRCMVMDR1.1 (24) , containing a human MDR1 cDNA. S1(MRP) and S1(MDR1) are transfectants of the non-small cell lung cancer cell line SW-1573/S1 that overexpress either human MRP or MDR1 cDNAs (4, 14) .
Immunocytochemistry. Cells were grown on microporous polycarbonate membrane filters (3.0 m pore size, 24.5 mm diameter, Transwell TM 3414; Costar Corp., Cambridge, MA) at a density of 2 ϫ 10 6 cells per well. Cells were grown for 3 d with one medium replacement. For confocal laser scanning microscopy, cells were washed in PBS and fixed for 10 min in 3% (vol/vol) formaldehyde in PBS, followed by permeabilization with 1% (vol/vol) Triton X-100 for 5 min. Filters were incubated for 60 min with mAb MRPr1 (1:500; 5). Antibody binding was detected with a FITC-labeled rabbit anti-rat IgG (1:50; Nordic, Tilburg, The Netherlands). The filters were mounted with Vectashield (Vector Laboratories, Burlingame, CA) containing propidiumiodide (1 g/ml) for counterstaining of nucleic acids. Cells were examined with a MRC-600 confocal microscope (Bio Rad, Hertfordshire, UK) coupled to a Nikon microscope equipped with a ϫ 60 objective. For immunoelectron microscopy, cells were grown on glass slides precoated with formvar and fixed in 4% (wt/vol) paraformaldehyde and 0.5% (vol/vol) glutaraldehyde in 0.1 M phosphate buffer, pH 7.2. Cells and formvar were removed together from the slide and embedded in 10% (wt/vol) gelatin in PBS. Ultrathin frozen sections were incubated with mAb MRPr1 (1:100), followed by rabbit anti-rat IgG (1:40) and goat anti-rabbit IgG (1:40) linked to 10-nm gold particles (Amersham, Den Bosch, The Netherlands). Incubations were for 1 h at room temperature. After immunolabeling, the cryosections were embedded in methylcellulose/uranylacetate and examined with a Philips CM 10 electron microscope (Philips, Eindhoven, The Netherlands). Transport assays. [ 3 H]daunorubicin transport assays were carried out as described (21) . Briefly, cells were seeded on microporous polycarbonate filters (see immunocytochemistry) at a density of 2 ϫ 10 6 cells per well and grown for 3 d. Experiments were started (t ϭ 0) by replacing the medium at either the apical or the basolateral side of the monolayer with 2 ml of medium containing the appropriate concentration of radiolabeled daunorubicin (at 0.25 Ci/ml, 2 M), and 14 C-labeled inulin (0.025 Ci/ml, 4.2 M). The cells were incubated at 37 Њ C in 5% CO 2 , and 50-l aliquots were taken from each compartment at 1, 2, 3, and 4 h. The appearance of radioactivity in the opposite compartment was measured and presented as the fraction of total radioactivity added at the beginning of the experiment. The paracellular flux was monitored by the appearance of inulin-[
14 C]carboxylic acid in the opposite compartment and was always Ͻ 1.5% of total radioactivity per h. For determination of intracellular [ l aliquots were taken at various time points. As excretion of GS-[ 14 C]DNP was extremely rapid at 37 Њ C, incubations were done at 23 Њ C. Samples were immediately extracted with 200 l of ethylacetate and centrifuged for 2 min (12,000 g ). Radioactivity in 160 l of both phases was determined by liquid scintillation counting. The amount of radioactivity was corrected for the decrease in volume of the culture medium. In case inhibitors were used during the incubation period, cells were first incubated with medium containing the appropriate concentration of inhibitor at 37 Њ C in 5% CO 2 for 10 min. To determine intracellular GS-[ 
Results

Generation of LLC-PK1 cells expressing human MRP.
To study transport properties of MRP we transfected a human MRP cDNA expression vector (4) into the polarized pig kidney epithelial cell line LLC-PK1. RNase protection using a probe for the human MRP cDNA confirmed that one selected clone contained a high level of MRP RNA, whereas no human MRP RNA was detected in parental LLC-PK1 cells or in LLC-MDR1 cells (data not shown). The MRP -overexpressing transfectant (LLC-MRP) was threefold resistant to vincristine compared to the untransfected LLC-PK1 cells in a clonogenic survival assay.
Western blot analysis of crude membrane fractions of LLC-PK1 cells, LLC-MRP, and LLC-MDR1 with the mAb Figure 1 . MRP and MDR1 levels in crude membrane fractions from LLC-PK1 derived clones. 20 g of protein was size fractionated in a 7.5% (wt/ vol) polyacrylamide gel containing 0.1% (wt/vol) SDS. After electroblotting, MRP was visualized by staining with mAb MRPr1 (lanes 1-3) , MDR1 by staining with mAb C219 (lanes 4-6) . The identity of the cell lines analyzed is indicated over the lanes.
MRPr1 (5) revealed that LLC-MRP contained a substantial amount of MRP (Fig. 1, lanes 1-3 ) . We were unable to detect MRP in the parental LLC-PK1 or in LLC-MDR1 cells, even after prolonged exposure under conditions where the basal level of MRP in human SW-1573 lung cancer cells was easily detectable (data not shown). As MRP appears to be ubiquitously expressed in human cell lines, we assume that the mAb MRPr1 does not cross-recognize the endogenous porcine homologue of MRP. Incubation of the same blot with mAb C219 demonstrated that Pgp was readily detectable in LLC-MDR1 cells (Fig. 1, lane 5 ) . Long exposure revealed the low basal level of Pgp present in LLC-PK1 and LLC-MRP cells, and demonstrated that there was no increase in endogenous Pgp level in LLC-MRP cells (not shown).
Immunolocalization of MRP. To investigate the subcellular localization of MRP, LLC-MRP, and LLC-PK1 cells were grown to confluency on microporous membrane filters to establish optimal polarization, and MRP was visualized by indirect immunofluorescence using confocal laser-scanning microscopy. A top view of the epithelial cell layer shows a clear staining of the plasma membranes of the LLC-MRP cells with mAb MRPr1 (Fig. 2 A ) , whereas the parental LLC-PK1 cells hardly stained at all (Fig. 2 B ) . Weak staining was observed in the cytoplasm of LLC-MRP cells, possibly representing a low level of MRP in intracellular membranes. Unexpectedly, examination of the cells at the plane perpendicular to the membrane filter showed that almost all MRP immunostaining was confined to the lateral membranes, whereas the apical membranes did not show significant staining (Fig. 2 A , lower rectangular panel ) .
The lateral localization of MRP was confirmed by immunoelectron microscopy. Ultrathin frozen sections of LLC-MRP cells and LLC-PK1 cells were cut perpendicular with respect to the cell layer and incubated with mAb MRPr1, followed by rabbit anti-rat IgG and goat anti-rabbit IgG linked to 10-nm gold particles. A typical picture is shown in Fig. 3 A. Gold particles were mainly confined to the basolateral membrane, although some particles were also visualized on the apical membrane, in the cytosol, and in mitochondria. Whereas no basolateral staining was found in parental LLC-PK1 cells, some apical and mitochondrial signals were also observed in these cells, suggesting that they were due to background binding ( Fig. 3 B and C ) .
Export of dinitrophenyl-glutathione by LLC-MRP cells. Jedlitschky et al. (7) and Müller et al. (8) showed that dinitrophenyl-glutathione (GS-DNP) is transported into membrane vesicles prepared from MRP -overexpressing cells. To investigate whether GS-DNP is also a substrate for MRP in intact cells, transport was analyzed in LLC-PK1, LLC-MDR1, and LLC-MRP cells. We used [ To distinguish transport of GS-[ 14 C]DNP across the apical membrane (apical transport) from transport across the basolateral membrane (basolateral transport), cells were allowed to form a tight epithelial monolayer on microporous membrane filters. Under these conditions, substrates pumped across the apical membrane accumulate in the apical compartment, whereas substrates pumped across the basolateral membrane accumulate in the basal compartment.
Analysis of GS-[ and Table I ). The intracellular level of GS-[ These experiments showed that overexpression of MRP is correlated with increased basolateral glutathione S-conjugate export activity. To test whether this transport system resembles the GS-X pump, we used sulfinpyrazone, a well known inhibitor of organic anion transport (26) . In the presence of 1 mM sulfinpyrazone the basolateral efflux of GS-[ 14 C]DNP decreased in all three cell lines, but it remained two to threefold higher in LLC-MRP. The apical transport was only slightly decreased (LLC-PK1), or even somewhat increased (LLC-MDR1, LLC-MRP; Fig. 4 B) . At higher sulfinpyrazone concentrations (2 and 4 mM; Table I ). Indeed, the total amount of GS-[ 14 C]DNP detected after 20 min in cells and medium combined remained comparable at all sulfinpyrazone concentrations. Probenecid, another well-known inhibitor of organic anion transport (27) produced similar effects as sulfinpyrazone, although 10 mM was needed to get an effect comparable to that found with 1 mM sulfinpyrazone (data not shown). 
Basolateral transport of [
Discussion
This study shows that the human MRP is predominantly routed to the basolateral membrane of LLC-PK1 pig kidney epithelial cells, where it mediates preferential transport of the glutathione S-conjugate GS-DNP, and of the anticancer drug daunorubicin to the basal side of the cell layer. This MRPmediated transport to the basal side is specifically inhibited by probenecid and sulfinpyrazone, compounds that do not detectably affect the MDR1 Pgp-mediated transport of daunorubicin to the apical side. Our results confirm that MRP can increase the export of a GSH S-conjugate from living cells, as was predicted from previous in vitro experiments (7, 8) . We do not know whether daunorubicin is transported by MRP as a shortlived complex with, e.g., GSH, or as unchanged drug. Previous experiments with MRP-overexpressing cells indicate that a putative transported daunorubicin-GS complex (if it exists at all) is too short-lived in medium for HPLC detection (14) . Attempts to demonstrate MRP-mediated polarized transport of other MRP substrate anticancer drugs in LLC-MRP cells failed for various reasons: vincristine and etoposide did not enter the cells fast enough to perform reliable transport studies, and vinblastine translocation was dominated by the endogenous pig Pgp.
Our findings indicate that sulfinpyrazone and probenecid are relatively specific inhibitors of MRP-mediated transport of daunorubicin that do not affect MDR1-mediated transport. Therefore, we have also tested whether these compounds could reverse the MRP-mediated vincristine resistance of SW-1573 human lung cancer cells transfected with an MRP cDNA (4). Preliminary results indicate that these compounds can indeed partially reverse vincristine resistance in S1(MRP) cells, but not in SW-1573 cells overexpressing MDR1. However, reversal was partial, and both sulfinpyrazone and probenecid had to be used at near-toxic dosages. Nevertheless, high doses of both compounds have been used clinically (28) , so if MRP contributes to clinical drug resistance of tumors, they might be useful lead compounds for the development of less toxic and more specific reversal agents.
The basolateral localization of MRP came as a surprise to us, as we had expected an excretory function of this class of protein in the intact organism, which would be more compatible with an apical localization, as found for the MDR1 Pgp. Nevertheless, all experiments, including immunolight microscopy, immunoelectron microscopy, and the transport studies, confirm the basolateral localization. LLC-PK1 cells perform regular polarized sorting of membrane proteins, as was previously shown for instance by the correct basolateral routing of the Na, K-ATPase, and the proper apical routing of the related H, K-ATPase (29). Human MDR1 and mouse mdr1a P-glycoprotein are also correctly routed to the apical membrane in these cells (20, 21) . We therefore think that MRP is properly sorted in LLC-PK1 cells. Sorting to either apical or basolateral plasma membranes is mediated by specific signals in proteins (for review see reference 30). Although amino acid residues important for basolateral sorting have been identified in the cytosolic tail of several single-spanning membrane proteins, no definitive consensus sequence has been clarified yet (for review see reference 31). Whether multispanning membrane proteins like MRP (or Pgp) use similar signals remains to be seen.
It is interesting to note that the endogenous GS-DNP export activity found in LLC-PK1 cells also demonstrates preferential transport to the basal side (Fig. 4 A) , and that this basolateral transport activity is relatively more sensitive to sulfinpyrazone (and probenecid) than the apical GS-DNP transport activity (Fig. 4 B) . The MRP-mediated basolateral transport in LLC-MRP is also more sensitive to sulfinpyrazone than the (endogenous) apical transport (Fig. 4 B) . Only at higher sulfinpyrazone concentrations were both apical and basolateral transport efficiently blocked (Fig. 4, C and D) . Preferential, ATP-dependent, basolateral transport of GS-DNP was previously also found in polarized human Caco-2 colon carcinoma epithelial cells (25) . That MRP could be involved in GS-DNP transport in these cells is suggested by Western blot analysis, which showed the presence of MRP in Caco-2 cells, albeit at a low level (data not shown).
These findings lead us to propose that there exist at least two different endogenous GS-DNP transport systems in the LLC-PK1 parental cells, one with an apical localization and somewhat lower sensitivity to sulfinpyrazone, and another with a basolateral localization and somewhat higher sensitivity to sulfinpyrazone. Based on the cellular localization and the sensitivity to sulfinpyrazone, the human MRP seems to be more closely related to the latter transport system, which might represent a pig homologue of MRP. Other researchers have also found indications for the coexistence of multiple distinct ATP-dependent GS-DNP transport systems in one cell line (e.g., 32). Multiplicity of MRP-like transporters is further suggested by the recent entry of four MRP-like partial human cDNA sequences in the GenBank/EMBL database. Moreover, Oude Elferink et al. (33) demonstrated that the TR Ϫ mutant rat strain, which is deficient in the bile canalicular excretion of GS-DNP performed by hepatocytes of normal rats, still performs normal (and saturable) GS-DNP transport across the sinusoidal membrane of hepatocytes. This finding further supports the existence of at least two distinguishable GS-DNP export systems. As the hepatocyte sinusoidal membrane is in many respects comparable to the basolateral membrane of epithelial cells, the GS-DNP export system not affected in TR Ϫ rats appears to be sorted to the basolateral membrane domain, just like MRP in LLC-PK1 cells. The basolateral or sinusoidal GS-DNP transporter of rats might therefore represent a rat homologue of the human MRP.
It is tempting to speculate about a possible relationship between the probenecid-and sulfinpyrazone-inhibitable excretion of organic anions in the kidney and MRP. Based on the presence of several markers, LLC-PK1 cells are probably derived from the proximal part of the kidney tubules (34) . Unfortunately, in contrast to the extensive studies done in the liver, not much is known about GS-X pump activities in the kidney. Excretion of organic anions by the kidney is relatively complicated, and so far a basolateral uptake system and a lumenal organic anion exchange system have been detected in proximal tubular epithelia of the kidney (35) . Together, these systems appear to be responsible for the excretion, but sometimes also for tubular resorption, of organic anions. To our knowledge, no basolateral (or apical) GS-X pump activity has been identified in these cells yet. This may mean that GS-X pumps are not important for kidney excretory function, or, alternatively, that they have been missed in the analyses carried out so far. MRP expression is found in human kidney (15) . Hence, future analysis of kidney function might reveal a relevant contribution of MRP to the excretion or resorption of organic anions.
